Delivery Order SPE2DB22D1202-SPE2DB25FUGD6

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,851.79 firm fixed-price delivery order is for the supply of TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award is a delivery order worth $3,079.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,345.33 firm fixed-price delivery order is for the supply of 4564530304 - TROKENDI XR 50 MG CAPSULE 30S, a specialty medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,969.00 fixed-price delivery order is for the supply of Trokendi XR 100 mg capsules to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with an ID of SPE2DB25D3002|SPE2DB25FLPRB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,436.67 Firm Fixed Price Delivery Order contract is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a value of $2,019.15 and is a Firm Fixed Price Delivery Order for the product "TROKENDI XR 200 MG CAPSULE 30S". The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB25FT7E4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,965.33, is a delivery order for the supply of TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 3, 2025. It is not designated under any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,038.48 firm fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,891.22 firm fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of July 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the procurement of TROKENDI XR 100 MG CAPSULE 30S, a specialty pharmaceutical product. The contract has a firm fixed price of $2,582.64 and a period of performance through September 6, 2024. Amerisourcebergen is a large pharmaceutical distributor that holds multiple indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUGD6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,064.50 firm fixed-price delivery order is for the supply of 4566177898 TROKENDI XR 100 MG CAPSULE 30S, with an ultimate completion date of October 23, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded without any set-aside designation, indicating open competition. No subcontractor information was provided.

Generated 1/22/25, 12:57 AM